LGND SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ligand Pharmaceuticals ...
January 09 2017 - 1:08PM
Business Wire
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the Southern District of
California on behalf of investors who purchased Ligand
Pharmaceuticals Inc. (NASDAQ: LGND) securities between November 9,
2015 and November 14, 2016.
Click here to learn about the case:
http://www.wongesq.com/pslra/ligand-pharmaceuticals. There
is no cost or obligation to you.
According to the complaint, during the Class Period, Defendants
made false and/or misleading statements and/or failed to disclose
that: (1) Ligand overstated the value of certain Deferred Tax
Assets by approximately $27.5 million; (2) Ligand’s outstanding
convertible senior unsecured notes due 2019 should have been
classified as short-term debt rather than long-term debt as of
December 31, 2015; (3) Ligand did not maintain effective controls
over the accuracy and presentation of the accounting for income
taxes related to complex transactions; (4) in turn, Ligand lacked
effective internal control over financial reporting; and (5) as a
result, Defendants’ statements about Ligand’s business, operations
and prospects were materially false and misleading and/or lacked a
reasonable basis at all relevant times.
If you suffered a loss in Ligand you have until January 17, 2017
to request that the Court appoint you as lead plaintiff. Your
ability to share in any recovery doesn’t require that you serve as
a lead plaintiff. To obtain additional information, contact Vincent
Wong, Esq. either via email vw@wongesq.com, by telephone at
212.425.1140, or visit
http://www.wongesq.com/pslra/ligand-pharmaceuticals.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights. Attorney advertising.
Prior results do not guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170109006170/en/
The Law Offices of Vincent WongVincent Wong, Esq.Tel.
212.425.1140Fax. 866.699.3880vw@wongesq.com
Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From Sep 2023 to Sep 2024